CYduct Diagnostics Inc (CYDX)

[BERKSHIRE AGENT]

Nothing compares to cancer stocks; especially breast cancer. SNDY has the technology to effectively diagnose breast cancer in women and they are creating more advanced medical mammoview diagnostic systems as the increase in breast cancer in women rises with the growing population. VKN* does not compare. SNDY has what it takes to get to the next level. We could even see a run up to $1 dollar. Anything is possible with a real company, with real products and a real vision!